Composition for treating cellulite, and microneedle including same

Patent metadata

Field	Value
Publication number	US-10869905-B2
Application number	US-201716329553-A
Country	US
Kind code	B2
Filing date	Aug 29, 2017
Priority date	Aug 31, 2016
Publication date	Dec 22, 2020
Grant date	Dec 22, 2020

Abstract

In a composition and a microneedle for a localized obesity treatment containing the same in accordance with the present disclosure, the composition in accordance with the present disclosure contains a gelatin, decomposes a fat in a body, and inhibits lipogenesis and fat deposition in the body.

First claim

What is claimed is:

1. A method for treating an individual having localized obesity, the method comprising administering a composition comprising animal-derived gelatin to the individual at a location where the individual has localized obesity,
wherein the composition is administered by injection with a hypodermic needle or with a microneedle to skin tissue below the skin stratum corneum, and
wherein the composition reduces adipocyte size in adipose tissue at the location where the individual has localized obesity.

2. The method of claim 1 , wherein the composition is administered with the hypodermic needle.

3. The method of claim 1 , wherein the individual is obese.

4. The method of claim 1 , wherein the animal derived gelatin is a swine-derived gelatin.

5. The method of claim 1 , wherein the animal derived gelatin is cross-linked.

6. The method of claim 5 , wherein the cross-linked gelatin is cross-linked with genipin.

7. The method of claim 1 , wherein the composition is administered with the microneedle.

8. The method of claim 7 , wherein the microneedle comprises a tip portion having a length equal to or greater than a thickness of a skin stratum corneum of the individual.

9. The method of claim 8 , wherein the microneedle is applied onto skin of the individual and at least a portion of the tip portion of the microneedle is located below the skin stratum corneum,
wherein the tip portion comprises the composition, and
wherein the tip portion decomposes at a position below the skin stratum corneum such that the composition is released from the tip portion and locally decomposes adipose tissue and locally inhibits lipogenesis and fat-deposition.

10. The method of claim 8 , wherein the tip portion has a length of 10 μm to 300 μm.

11. The method of claim 10 , wherein the microneedle further comprises a patch layer having a surface on which the tip portion is disposed.

12. The method of claim 11 , wherein the patch layer is in contact with the skin and at least a portion of the tip portion is located below the skin stratum corneum.

Assignees

• Pusan National Univ Industry Univ Cooperration Foundation
• Nat Univ Pusan Ind Univ Coop Found

Inventors

• Yang Seung Yun
• An Beum Soo
• Seong Keum Yong
• An Sung Min

Classifications

• A61Q19/06

  for countering cellulitis · CPC title

• A61M2037/0023

  Drug applicators using microneedles · CPC title

• A61M37/0015

  by using microneedles · CPC title

• A61K38/014 Primary

  from connective tissue peptides, e.g. gelatin, collagen · CPC title

• A61K9/0021

  Intradermal administration, e.g. through microneedle arrays or needleless injectors · CPC title